Yervoy, also known by its generic name ipilimumab, is a type of monoclonal antibody used as an immunotherapy for cancer. Developed by Bristol-Myers Squibb, Yervoy is primarily used to treat various forms of melanoma, but it has also shown promise in treating other types of cancers.
